Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2023

Dec 20, 2023

3114_iss_2023-12-20_4c7f1a76-1cea-461f-b0c6-99c605a46ffc.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer SynAct Pharma AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0008241491
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 18/12/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,796,964
Directly held voting rights 0
Indirectly held voting rights 1,796,964
Percentage
Directly held shares 5.05177 %
Directly held voting rights 0 %
Indirectly held voting rights 5.05177 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.05177 % 1,796,964
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 0.00281 % 1,000
Total 5.05458 % 1,797,964

Chain of controlling companies

Voting rights % Voting rights Company
1,750,551 4.92129 Nordnet Pensionsförsäkring AB
0.13329 Nordnet Livsforsikring AS
Group
total
holdings
Voting rights 1,797,964
Percentage of voting rights 5.05458

Published

20/12/2023 13:56

Contact
Name Felix Mandoki
Phone +46766110734 Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25